DiaMedica Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-John Fichthorn(5.2%),Dialectic Life Sciences SPV LLC(5.1%), etc.
DiaMedica Therapeutics | D: Filing D
DiaMedica Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Von Koch Thomas
DiaMedica Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner STAHLBERG JAN
DiaMedica Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Wambeke David J.
DiaMedica Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cundari Dominic R
DiaMedica Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Kellen Scott
DiaMedica Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pauls Dietrich John
DiaMedica Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Semba Charles Pauling
DiaMedica Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Pilnik Richard D.
DiaMedica Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Parsons James T.
DiaMedica Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lewis Tanya
DiaMedica Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kuntz Richard
DiaMedica Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Giuffre Randall Michael
DiaMedica Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lorianne Masuoka K.
DiaMedica Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Lorianne Masuoka K.
DiaMedica Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Semba Charles Pauling
DiaMedica Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kuntz Richard
DiaMedica Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Pilnik Richard D.
DiaMedica Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Parsons James T.
No Data
No Data